Skip to main content
. 2022 Jul 11;45(9):2118–2126. doi: 10.2337/dc21-2166

Figure 3.

Figure 3

Time course of mean plasma insulin (A), glucagon (B), aGLP-1 (C), and GIP (D) concentrations during the 14 h in-house period before and after 8 weeks of treatment with sotagliflozin 400 mg or empagliflozin 25 mg. BL, baseline (day −1); W8, end of treatment (day 56).